9 ARTICLES TAGGED "DRUG DISCOVERY"
Anthropic and Enveda are leading a revolution in drug discovery through advanced AI-powered biology. These breakthroughs offer new hope for treating complex diseases by significantly accelerating the path to effective clinical solutions.
OpenAI has acquired Orchestra Bio to launch Project Rosalind, a major leap in AI-driven drug discovery. This strategic move aims to transform life sciences research by streamlining complex biological data.
OpenAI researcher Miles Wang is in talks to launch a specialized AI startup focused on drug discovery. The $2B valuation underscores the massive potential for AI to revolutionize the pharmaceutical industry by accelerating research and clinical breakthroughs.
The AI-native transformation marks a critical shift from simple data generation to the rigorous validation of insights. Explore how this evolution is reshaping legal practice, drug discovery, and the funding landscape for 10x Science.
Anthropic is leveraging Claude’s superintelligence to tackle the complex challenges of rare disease drug discovery. By 2026, this AI-driven approach aims to reduce costs and accelerate life-saving treatments for patients worldwide.
GPT-5.4 is transforming drug discovery from a decade-long marathon into a rapid sprint. By integrating OpenAI’s latest model with advanced chemistry labs, autonomous AI chemists are now capable of developing life-saving medicines in just weeks.
Explore GPT-Rosalind, OpenAI's specialized AI poised to transform life sciences and chemistry. This AI is set to accelerate breakthroughs in drug discovery and genomics.
OpenAI has introduced GPT-Rosalind for specialized research in drug discovery and genomics, alongside GPT-5.4-Cyber, a model dedicated to strengthening global cybersecurity infrastructure through API grants and trusted access.
Anthropic has acquired stealth biotech startup Coefficient Bio, integrating a team of former Genentech researchers to accelerate AI applications in healthcare and life sciences. This move signals a major pivot toward specialized vertical AI in the medical field.